Annual SG&A
$31.40 M
+$3.20 M+11.34%
31 December 2023
Summary:
Dyne Therapeutics annual selling, general & administrative expenses is currently $31.40 million, with the most recent change of +$3.20 million (+11.34%) on 31 December 2023. During the last 3 years, it has risen by +$17.95 million (+133.51%). DYN annual SG&A is now at all-time high.DYN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$12.86 M
+$3.16 M+32.58%
30 September 2024
Summary:
Dyne Therapeutics quarterly selling, general & administrative expenses is currently $12.86 million, with the most recent change of +$3.16 million (+32.58%) on 30 September 2024. Over the past year, it has increased by +$5.84 million (+83.12%). DYN quarterly SG&A is now -47.77% below its all-time high of $24.62 million, reached on 31 March 2024.DYN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.95 B
-$294.51 M-11.07%
30 September 2024
Summary:
Dyne Therapeutics TTM selling, general & administrative expenses is currently -$2.95 billion, with the most recent change of -$294.51 million (-11.07%) on 30 September 2024. Over the past year, it has dropped by -$2.98 billion (-10110.90%). DYN TTM SG&A is now -14861.59% below its all-time high of $56.02 million, reached on 30 September 2024.DYN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.3% | +83.1% | -10000.0% |
| 3 y3 years | +133.5% | +105.5% | -10000.0% |
| 5 y5 years | +5973.5% | +1887.5% | -10000.0% |
DYN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.5% | -47.8% | +111.1% | -497.9% | at low |
| 5 y | 5 years | at high | +5973.5% | -47.8% | +1887.5% | <-9999.0% | at low |
| alltime | all time | at high | +5973.5% | -47.8% | +1887.5% | <-9999.0% | at low |
Dyne Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.86 M(+32.6%) | $56.02 M(+11.6%) |
| June 2024 | - | $9.70 M(-60.6%) | $50.18 M(+4.4%) |
| Mar 2024 | - | $24.62 M(+178.4%) | $48.09 M(+53.2%) |
| Dec 2023 | $31.40 M(+11.3%) | $8.84 M(+25.9%) | $31.40 M(+6.4%) |
| Sept 2023 | - | $7.02 M(-7.7%) | $29.51 M(-2.0%) |
| June 2023 | - | $7.61 M(-4.1%) | $30.10 M(+5.3%) |
| Mar 2023 | - | $7.93 M(+14.0%) | $28.58 M(+1.4%) |
| Dec 2022 | $28.20 M(-1.8%) | $6.96 M(-8.6%) | $28.20 M(-8.7%) |
| Sept 2022 | - | $7.61 M(+24.9%) | $30.91 M(+4.6%) |
| June 2022 | - | $6.09 M(-19.3%) | $29.55 M(-0.7%) |
| Mar 2022 | - | $7.55 M(-21.9%) | $29.75 M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $28.72 M(+113.6%) | $9.66 M(+54.4%) | $28.72 M(+12.4%) |
| Sept 2021 | - | $6.26 M(-0.6%) | $25.56 M(+10.4%) |
| June 2021 | - | $6.29 M(-3.3%) | $23.14 M(+27.2%) |
| Mar 2021 | - | $6.51 M(+0.1%) | $18.19 M(+35.3%) |
| Dec 2020 | $13.45 M(+382.7%) | $6.50 M(+69.3%) | $13.45 M(+64.9%) |
| Sept 2020 | - | $3.84 M(+186.4%) | $8.16 M(+64.4%) |
| June 2020 | - | $1.34 M(-24.0%) | $4.96 M(+37.0%) |
| Mar 2020 | - | $1.76 M(+45.7%) | $3.62 M(+94.9%) |
| Dec 2019 | $2.79 M(+438.9%) | $1.21 M(+87.2%) | $1.86 M(+187.2%) |
| Sept 2019 | - | $647.00 K | $647.00 K |
| Dec 2018 | $517.00 K | - | - |
FAQ
- What is Dyne Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Dyne Therapeutics?
- What is Dyne Therapeutics annual SG&A year-on-year change?
- What is Dyne Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly SG&A year-on-year change?
- What is Dyne Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Dyne Therapeutics?
- What is Dyne Therapeutics TTM SG&A year-on-year change?
What is Dyne Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of DYN is $31.40 M
What is the all time high annual SG&A for Dyne Therapeutics?
Dyne Therapeutics all-time high annual selling, general & administrative expenses is $31.40 M
What is Dyne Therapeutics annual SG&A year-on-year change?
Over the past year, DYN annual selling, general & administrative expenses has changed by +$3.20 M (+11.34%)
What is Dyne Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of DYN is $12.86 M
What is the all time high quarterly SG&A for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly selling, general & administrative expenses is $24.62 M
What is Dyne Therapeutics quarterly SG&A year-on-year change?
Over the past year, DYN quarterly selling, general & administrative expenses has changed by +$5.84 M (+83.12%)
What is Dyne Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of DYN is -$2.95 B
What is the all time high TTM SG&A for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM selling, general & administrative expenses is $56.02 M
What is Dyne Therapeutics TTM SG&A year-on-year change?
Over the past year, DYN TTM selling, general & administrative expenses has changed by -$2.98 B (-10110.90%)